(Hypertension. 1996;27:476-480.)
© 1996 American Heart Association, Inc.
Articles |
From the Department of Pathology and Laboratory Medicine (B.S., W.G.P., M.B.M., K.E.B.) and the Center of Molecular and Cellular Signaling (M.B.M.), Emory University, Atlanta, Ga.
Correspondence to Kenneth E. Bernstein, MD, Room 711 WMB, Department of Pathology and Laboratory Medicine, 1639 Pierce Dr, Emory University, Atlanta, GA 30322.
Abstract Angiotensin II is the major effector
peptide of the renin-angiotensin system. In addition to
its vasoconstrictor activity, angiotensin II stimulates
smooth muscle cell growth in arterial hypertension and in
models of vascular injury. The angiotensin II type 1
receptor is a seven-transmembrane receptor and is responsible for
virtually all the physiological actions of
angiotensin II. This class of receptor signals in part
through its association with heterotrimeric G proteins. A newly
developed concept for guanine nucleotide
proteincoupled receptors is the activation of intracellular
second-messenger proteins via tyrosine
phosphorylation. For instance, angiotensin
II stimulates the rapid tyrosine phosphorylation and
activation of phospholipase C-
1. Also, angiotensin II
stimulates the tyrosine phosphorylation of Janus
kinases. In this review, we discuss early signaling events induced by
angiotensin II with an emphasis on tyrosine
phosphorylation. Understanding the importance of
tyrosine phosphorylation in the signaling pathways of
the angiotensin II type 1 receptor may lead to new
treatment modalities for cardiovascular disease.
Key Words: receptor, angiotensin II signal transduction phospholipase C-
1 protein-tyrosine-phosphatase protein tyrosine kinase
This article has been cited by other articles:
![]() |
N. J. Smith and L. M. Luttrell Signal Switching, Crosstalk, and Arrestin Scaffolds: Novel G Protein-Coupled Receptor Signaling in Cardiovascular Disease Hypertension, August 1, 2006; 48(2): 173 - 179. [Full Text] [PDF] |
||||
![]() |
A. Hus-Citharel, X. Iturrioz, P. Corvol, J. Marchetti, and C. Llorens-Cortes Tyrosine Kinase and Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase Differentially Regulate Intracellular Calcium Concentration Responses to Angiotensin II/III and Bradykinin in Rat Cortical Thick Ascending Limb Endocrinology, January 1, 2006; 147(1): 451 - 463. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. L. Schiffrin and R. M. Touyz From bedside to bench to bedside: role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H435 - H446. [Full Text] [PDF] |
||||
![]() |
Y.-P. Fan, R. N. Puri, and S. Rattan Animal model for angiotensin II effects in the internal anal sphincter smooth muscle: mechanism of action Am J Physiol Gastrointest Liver Physiol, March 1, 2002; 282(3): G461 - G469. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schieffer, M. Luchtefeld, S. Braun, A. Hilfiker, D. Hilfiker-Kleiner, and H. Drexler Role of NAD(P)H Oxidase in Angiotensin II-Induced JAK/STAT Signaling and Cytokine Induction Circ. Res., December 8, 2000; 87(12): 1195 - 1201. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Pallone, E. P. Silldorff, and Z. Zhang Inhibition of calcium signaling in descending vasa recta endothelia by ANG II Am J Physiol Heart Circ Physiol, April 1, 2000; 278(4): H1248 - H1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schieffer, E. Schieffer, D. Hilfiker-Kleiner, A. Hilfiker, P. T. Kovanen, M. Kaartinen, J. Nussberger, W. Harringer, and H. Drexler Expression of Angiotensin II and Interleukin 6 in Human Coronary Atherosclerotic Plaques : Potential Implications for Inflammation and Plaque Instability Circulation, March 28, 2000; 101(12): 1372 - 1378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Du, T. Peng, K. J. Scheidegger, and P. Delafontaine Angiotensin II Activation of Insulin-Like Growth Factor 1 Receptor Transcription Is Mediated by a Tyrosine Kinase–Dependent Redox-Sensitive Mechanism Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2119 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Luft, E. Mervaala, D. N. Muller, V. Gross, F. Schmidt, J. K. Park, C. Schmitz, A. Lippoldt, V. Breu, R. Dechend, et al. Hypertension-Induced End-Organ Damage : A New Transgenic Approach to an Old Problem Hypertension, January 1, 1999; 33(1): 212 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kodama, K. Fukuda, J. Pan, S. Makino, M. Sano, T. Takahashi, S. Hori, and S. Ogawa Biphasic Activation of the JAK/STAT Pathway by Angiotensin II in Rat Cardiomyocytes Circ. Res., February 9, 1998; 82(2): 244 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pan, K. Fukuda, H. Kodama, S. Makino, T. Takahashi, M. Sano, S. Hori, and S. Ogawa Role of Angiotensin II in Activation of the JAK/STAT Pathway Induced by Acute Pressure Overload in the Rat Heart Circ. Res., October 19, 1997; 81(4): 611 - 617. [Abstract] [Full Text] |
||||
![]() |
K. K. Griendling, M. Ushio-Fukai, B. Lassegue, and R. W. Alexander Angiotensin II Signaling in Vascular Smooth Muscle: New Concepts Hypertension, January 1, 1997; 29(1): 366 - 370. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |